Most Popular Angioplasty Web Site
Expert Insights & Feature Articles
Dr. Yusuke Yoshikawa
Utility of DAPT Score in Japanese Cohort
Dr. Yoshikawa discusses his study, just published in Circulation, titled "Validating Utility of DAPT Score in a Large Pooled Cohort from Three Japanese PCI Studies," and he comments on how the Japanese population differs from western patients in terms of bleeding and ischemic event rates. (posted in collaboration withTCROSS NEWS)
Dr. Etsuo Tsuchikane
Complex CTO-PCI: The Japanese Approach
This 20 minute video shows a complex CTO case, in which an RCA obstruction, complicated by a sharp bend and tortuous anatomy, was revascularized using both the antegrade and retrograde approaches, facilitated by IVUS and biplane angiographic imaging. The operator is Dr. Etsuo Tsuchikane; the case was broadcast live during the Japanese CTO Club course in June 2017. (from TCROSS NEWS)
CoreValve Evolut PRO
Medtronic's Evolut PRO Now Available in Europe
Medtronic has announced that its latest transcatheter aortic valve, the CoreValve Evolut PRO, has received the CE mark and is now available for use in Europe. This new generation valve utilizes a biocompatible porcine outer wrap that increases surface contact and sealing to reduce paravavular leaks (PVL).
Absorb BVS
Clinical Trial to Study If 3-Months of DAPT is Safe After XIENCE Stent
The study, called XIENCE Short DAPT, will evaluate if 3 months of DAPT is non-inferior to the current standard of 12 months after implantation with a XIENCE stent for patients who are at high risk of bleeding. The study will enroll approximately 2,000 patients at 100 sites in the U.S. and Asia.
3 generations of CoreValve
FDA OK to Medtronic's CoreValve for Patients at Intermediate Risk for Surgical Replacement
Based on results from the SURTAVI Trial, the FDA has approved the CoreValve TAVR self-expanding platform for use in patients with symptomatic and severe aortic stenosis who are at intermediate risk for surgical valve replacement.
Shun Kohsaka, MD
Barriers to Achieving Optimal Door-to-Balloon Time in Japan
Interview with Dr. Shun Kohsaka
In this interview, from TCROSS NEWS, co-author Dr.Shun Kohsaka discusses a study, recently published in the Japanese Circulation Society's Circulation Journal, demonstrating that DTB time in half of STEMI cases in Japan is greater than 90 minutes.
Osamu Iida, MD
Prognostic Impact of Revascularization in Poor-Risk Patients with Critical Limb Ischemia
Interview with Dr. Osamu Iida
In this interview, from TCROSS NEWS, Dr. Iida discusses the PRIORITY Study, published in the June 12 issue of JACC: Cardiovascular Interventions. This registry looked at over 600 patients in 37 hospitals across Japan to see if revascularization had any impact on survival at one-year.
Absorb BVS
Absorb Bioresorbable Vascular Scaffold in Europe: Now Only Available to Approved Registry Sites
Abbott Vascular has ceased distribution of its Absorb BVS in Europe to all but certified registry sites for one year, at which time, the data collected on performance of the Absorb device will be re-evaluated.
Yutaka Tanaka, MD, PhD
Transradial Coronary Interventions for Complex Chronic Total Occlusions
Interview with Dr. Yutaka Tanaka
In this interview, from TCROSS NEWS, Dr. Tanaka discusses his group's study on transradial coronary interventions for complex chronic total occlusion, just published in JACC: Cardiovascular Interventions. The patient population for this single-center study comprised almost 600 patients and looked at whether the transradial approach was feasible for complex chronic total occlusions.
Medtronic Goes Radial
Medtronic's TRAcelet™ compression device
Medtronic is now offering a full portfolio of transradial tools: a line of catheters, a TRA access kit with introducer sheath, and its TRAcelet™ compression device for simplifying patent hemostasis post-procedure. Although the company previously has marketed a select number of items designed for the transradial approach (TRA), today's announcement marks the first full-transradial offering by a major stent manufacturer in the U.S.
Medtronic Announces Reimbursement Approval and Launch of CoreValve™ Evolut™ R System in Japan
Medtronic CoreValve Evolut R
The recapturable, self-expanding transcatheter CoreValve™ Evolut™ R System from Medtronic has received reimbursement approval from the Japanese Ministry of Health, Labor and Welfare (MHLW). This new generation TAVR device is indicated for patients with severe aortic stenosis (AS) unable to undergo surgery, and for whom treatment with transcatheter aortic valve implantation is determined to be the best option.
NORSTENT: Drug-Eluting Stents – Doing What They’re Supposed To
HawkOne atherectomy device and IN.PACT drug-coated balloon
At this week’s annual European Society of Cardiology Congress in Rome, an important randomized clinical trial on stents was presented by Professor Kaare H. Bønaa, MD, PhD. Called NORSTENT, short for the “Norwegian Coronary Stent Trial,” this was the largest stent trial ever conducted, with 9,013 patients followed for six years. That’s serious!
COURAGE: Does 15-Year Data Have Any Clinical Relevance?
Pills and stent
From the Editor: "I think that this 15-year analysis has so many statistical weaknesses, and is looking at a snapshot in time that has long been surpassed by advances in technology and practice, that the conclusion of this “extended survival analysis” is basically irrelevant to current practice."
European Guidelines Say "Radial First"
transradial access
Today the European Society of Cardiology (ESC) gave the highest recommendation to the radial (wrist) approach for catheter-based interventions in patients with acute coronary syndromes (ACS). The "ACS without persistent ST-segment elevation (NSTE-ACS) guidelines," drafted by an international multidisciplinary Task Force, were introduced as part of this year's annual ESC meeting, and are now published online.
Medtronic Begins Trial for Next-Generation Drug-Eluting Stent in Small Arteries
Medtronic Resolute Onyx stent picture on map of U.S.
Medtronic is beginning the U.S. pivotal trial for its new drug-eluting stent, the Resolute Onyx™. The Onyx received the European CE Mark in November and has been available in countries that recognize the CE Mark. The first phase of this trial will be studying one of the most challenging clinical scenarios: blockages in arteries that measure as small as 2.0mm.
Interventional Cardiologist Dr. Sanjay Patel
"The Whole Story is About Increasing Patient Happiness."
Interview with Dr. Ferdinand Kiemeneij
In this two-part 20th anniversary interview, the "father of transradial intervention, " talks about the history and future of TRI.

Angioplasty News

RSS Angioplasty News Feed Get our RSS News Feed
Dr. Yoshikawa discusses the DAPT Score in a Japanese Cohort (Nov 10)
VIDEO: Complex CTO-PCI: The Japanese Approach with Dr. Etsuo Tsuchikane (Oct 31)
Medtronic's Evolut PRO Now Available in Europe (Jul 31)
Abbott Study: Is 3 Months of DAPT After XIENCE OK? (Jul 25)
FDA OK to CoreValve TAVR for Intermediate Risk Patients (Jul 10)
Dr. Shun Kohsaka: half the STEMI cases in Japan have a DTB time of > 90 min. (Jun 30)
Dr. Osamu Iida discusses the PRIORITY registry and if there is benefit for revascularization in poor-risk CLI patients (Jun 19)
History, Gruentzig, and Abbott’s Absorb “Dissolving Stent” (Apr 6)
UPDATED: Abbott's Absorb BVS in Europe Will Only Be Available to Approved Registry Sites (Apr 6)
FDA OK to Medtronic's Next-Gen CoreValve TAVR (Mar 22)
First U.S. Case Done with Tryton's Side Branch Stent (Mar 21)
Interventional Cardiology Late-Breakers at ACC.17 (Mar 16)
Micra Leadless Pacemaker Gets OK for U.S. Reimbursement (Mar 10)
IN.PACT DCB Below-The-Knee Study Launched in Europe (Mar 9)
New Analysis of REVERSE Trial Shows Benefits of Medtronic CRT Devices (Feb 27)
Dr. Yutaka Tanaka discusses the transradial approach to complex CTO lesions (Feb 21)
Medtronic Goes Radial (Feb 13)
IN.PACT Japan Study: DCB Increases Patency 86% Over PTA (Feb 9)
Medtronic CardioInsight Mapping Solution Cleared by FDA (Feb 1)
6F HawkOne Gets CE Mark (Jan 24)
Medtronic's 34mm CoreValve Evolut R Gets CE Mark (Jan 17)
Abbott's Acquisition of St. Jude to Close This Week (Jan 2)
Dr. Masanori Yamamoto Discusses Approval of CoreValve Evolut R and TAVR landscape in Japan (Dec 8)
Medtronic's Endurant™ II/IIs Receives CE Mark for Use with ChEVAR Parallel Graft Technique (Dec 6)
Japan Announces Regulatory Process & Post Marketing Surveillance for Abbott BVS (Dec 5)
CoreValve Gets Reimbursement OK in Japan (Dec 1)
Medtronic's Endurant™ II/IIs Delivers Positive Outcomes in Patients with Challenging AAA (Nov 15)
Absorb Bioresorbable Vascular Scaffold Gets OK in Japan (Nov 7)
Interview with Dr. Hiroki Shiomi About the ReACT Study (Nov 4)
BIO-RESORT: Biodegradable Polymers Provide No Clinical Benefit Over Resolute Integrity (Oct 30)
FDA OKs New Recaptureable CoreValve TAVR for Patients with Large Anatomies (Oct 26)
Coronary Angioplasty Enters Its 40th Year (Sep 16)
Medtronic's IN.PACT DCB Gets FDA OK for ISR in Peripherals (Sep 13)
NORSTENT: Drug-Eluting Stents – Doing What They’re Supposed To (Aug 30)
Medtronic Technologies Improve Delivery of Cardiac Resynchronization Therapy (Aug 29)
New Long-Term Data Reinforce Safety Benefits of the World's Smallest Pacemaker (Aug 28)
AimRADIAL Masterclass V + FFR Workshop in Budapest (Aug 25)
Edwards SAPIEN3 Gets FDA OK for Intermediate Risk Patients (Aug 21)
Drug-Coated Balloon + Atherectomy for Calcified FemPop PAD? (Aug 4)
Urgent Recall for Lotus Valve (Aug 3)
CoreValve TAVR Gets CE Mark for Intermediate Risk patients (Aug 1)
Will Abbott's Absorb Bioresorbable Vascular Scaffold Revolutionize Treatment of CAD? (July 24)
Health Canada Approval for Abbott's Absorb "Dissolving Stent" (July 14)
FDA OK to 150mm IN.PACT DCB for Long Lesions in SFA (July 13)
Absorb Bioresorbable Vascular Scaffold Gets FDA OK (July 5)
Philips Volcano Activities at EuroPCR (May 15)
InterZENtion: Transradial PCI as an Art (May 13)
An American Cardiologist in Paris (May 11)
FDA Approves World's Smallest Pacemaker for U.S. Patients (Apr 6)
CoreValve: 3-yr Survival Advantages Over Surgery in High Risk Aortic Stenosis Patients (Apr 3)
30 Day Data on Medtronic's Drug-Filled Stent (Apr 3)
CoreValve Bests SAVR in "Intermediate Risk" Aortic Stenosis Patients (Apr 2)
Philips Volcano: 5,000+ Patients Enrolled in 3 iFR Trials (Apr 1)
Visit current news, and news archives

Burt Cohen, Editor of Angioplasty.Org
"Voice in the Ear": Editor Burt Cohen's stent and device blog.

Recent Posts:

The Activated Patient
"The Activated Patient": Patient info and empowerment blog
Patients Are Talking About...
  • I had radial angiography 2 days was a fascinating experience and was able to watch part of the procedure. I feel fantastic, have no "heart ache" or any problems with my arm.
  • I can't afford my post-stenting meds, where can I find help paying for Plavix or Effient?
  • I'm 64. After 4 stents and 2 heart attacks since Dec. 2008, I'm as physically active or more so than ever. I plan to hit 4,000 miles on my bike this year. I've hiked/climbed at 13,000 feet.
Patients Are Reading About...
Plavix and Stent
Patient Alert!: How to Get the Best Price on New Generic Plavix
Our survey found prices from 35¢ to $6 per pill. Read on for more resources to help you get the most affordable antiplatelet drugs, plus a look at the role of online patient communities.
5 Crucial Questions To Ask Your Doctor About New Heart Disease Treatments
Make sure you are benefiting from the most up-to-date research, and have access to the treatments that best fit your needs and preferences.
   Doctor and Patient
Radial Hospital Locator
A list of physicians and hospitals offering the transradial (wrist) approach to angiograms, angioplasty and stent procedures.
  Transradial Hospital
Read patient stories and Learn about medications after stenting, symptoms and complications, care giving, taking charge of your health, communicating with your cardiologist and much more in our Patient Center.
Angioplasty Inventor, Dr. Andreas Gruentzig
see video clip:
" The 1st Angioplasty"
ANGIOPLASTY AT 35: 2012 marked the 35th anniversary of coronary angioplasty. In 1977 in Zurich, Switzerland, a young physician named Andreas Gruentzig inserted a catheter into a patient's coronary artery and inflated a tiny balloon, successfully opening a blockage and restoring blood flow to a human heart.
Today over two million coronary angioplasties are performed worldwide each year and angioplasty has become the gold standard for emergency heart attack treament.
(View videos, interviews, and photos in our Angioplasty History Center, or order our DVD, "PTCA: A History.") Angioplasty History DVD
What People Are Saying About Angioplasty.Org:
"Everyone, please consider donating to this site, it is a wealth of information and comfort. Where else can you get such great information AND expedited? My dr's don't return phone calls as quickly as I've gotten responses here!" -- Denise, Connecticut, USA
"Angioplasty.Org is awesome; I always refer patients to it. It makes a difference big time. They go and they look and see all the people interviewed and these well-known cardiologists around the world talking about it, and it takes that anxiety away." -- Sanjay Patel, MD, Houston, Texas, USA
"Thanks to Angioplasty.Org for all the info which helped a lot in my decision making and post procedure recovery." -- Muralidharan, Chennai, India
"Burt Cohen (Senior Editor of Angioplasty.Org) has been documentarian of this field of medicine for 30 years" -- Dr. Stephen Oesterle, SVP Medicine and Technology, Medtronic Corp.
"I just want you to know that you probably saved [my husband's] life by telling your story, and I want to thank you for it." -- Marie, Canada
Like your local educational TV or radio station, Angioplasty.Org relies on help from visitors like you. The grant funding we receive does not fully cover our costs; please consider making a recurring monthly contribution or a one-time donation.
Thank You to Our Industry Grantmakers:
Medtronic, Inc.
Volcano Corporation
Toshiba America
Medical Systems
Cardium Therapeutics
Lenox Hill Heart and Vascular Institute of NY
Freddie Award for International Health and Medical Media
Britannica Selection
Selected as an "Internet iGuide" by Encyclopedia Brittanica
    Health On the Net

send comments & suggestions to "info at angioplasty dot org"
Read our Privacy statement.

Angioplasty.Org is an editorially independent informational health site
which has received unrestricted educational grants from
Medtronic plc, TCROSS NEWS, Toshiba America Medical Systems, Volcano Corporation, Terumo Medical Corporation
Cardium Therapeutics, Inc. and Lenox Hill Heart and Vascular Institute of NY

For more information, see About Us
All content, including text, photos and video
© Copyright Venture Digital LLC 1996-2017